1. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy;Likoff, M.J.; Chandler, S.L.; Kay, H.R.;Am J Cardiol,1987
2. Prognosis of congestive heart failure and predictors of mortality;Cohn, J.N.; Rector, T.S.;Am J. Cardiol,1988
3. Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics;Schwarz, F.; Mall, G.; Zebe, H.;Circulation,1984
4. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure;Cohn, J.N.; Levine, T.B.; Olivari, M.T.;NEnglJMed,1984
5. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II;Francis, G.S.; Cohn, J.N.; Johnson, G.; Rector, T.S.; Goldman, S.; Simon, A.;The V-HeFT VA Cooperative Studies Group. Circulation,1993